About
Gene Therapy for Cancer
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyNJ, NY, PA
Clinical Trials (16)
View allTotal Trials
16
As Lead Sponsor
13
As Collaborator
3
Total Enrollment
297
By Phase
PHASE1: 11EARLY_PHASE1: 5
By Status
UNKNOWN: 11RECRUITING: 5
Clinical Trials Pipeline16 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
Today
Hover over trial bars to see details
Recent Trials
NCT06787989Lead Sponsor
BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases
PHASE1Recruiting
20 participants
Started: Aug 31, 2024 · Completed: Apr 30, 2027
NCT06197672Collaborator
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant
PHASE1Recruiting
30 participants
Started: Mar 19, 2024 · Completed: Dec 31, 2042
NCT06071624Collaborator
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.
PHASE1Recruiting
30 participants
Started: Feb 21, 2024 · Completed: Dec 31, 2043
NCT05212584Lead Sponsor
CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma
PHASE1Unknown
24 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2024
NCT05445765Lead Sponsor
Anti-CD33 CAR-T Cells for the Treatment of Relapsed/Refractory CD33+ Acute Myeloid Leukemia
PHASE1Unknown
10 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2024
Locations (1)
Headquarters
Stony Brook, NY, United States
Map
Loading map...